|
|
|
|
| LEADER |
03062nam a22003255i 4500 |
| 001 |
000287849 |
| 005 |
20210901133458.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100316s2010 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781607615880
|
| 024 |
7 |
|
|a 10.1007/978-1-60761-588-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a RNA Interference :
|b From Biology to Clinical Applications /
|c edited by Wei-Ping Min, Thomas Ichim.
|
| 250 |
|
|
|a 1st ed. 2010.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2010.
|
| 300 |
|
|
|a XVI, 450 p. 82 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 623
|
| 505 |
0 |
|
|a Physiology of RNA Interference -- Endogenous Antiviral Mechanisms of RNA Interference: A Comparative Biology Perspective -- Monitoring Innate Immune Recruitment by siRNAs in Mammalian Cells -- Current Knowledge of MicroRNAs and Noncoding RNAs in Virus-Infected Cells -- Allele-Specific Silencing by RNA Interference -- Computational siRNA Design Considering Alternative Splicing -- Bioinformatic Approaches to siRNA Selection and Optimization -- Optimized Gene Silencing by Co-expression of Multiple shRNAs in a Single Vector -- Strategies in Designing Multigene Expression Units to Downregulate HIV-1 -- Designing Optimal siRNA Based on Target Site Accessibility -- Chemical Synthesis of 2?-O-Alkylated siRNAs -- RNA Interference in the Laboratory and siRNA Delivery -- siRNA Specific Delivery System for Targeting Dendritic Cells -- Hydrodynamic Delivery Protocols -- New Methods for Reverse Transfection with siRNA from a Solid Surface -- Nonviral siRNA Delivery for Gene Silencing in Neurodegenerative Diseases -- Using siRNA to Uncover Novel Oncogenic Signaling Pathways -- Biodegradable Polymer-Mediated sh/siRNA Delivery for Cancer Studies -- Cellular siRNA Delivery Using TatU1A and Photo-Induced RNA Interference -- Polyethylenimine (PEI)/siRNA-Mediated Gene Knockdown In Vitro and In Vivo -- Transfection of siRNAs in Multiple Myeloma Cell Lines -- Clinical Implementation -- A New Approach for Therapeutic Use by RNA Interference in the Brain -- Inhibitory RNA Molecules in Immunotherapy for Cancer -- Preventing Tissue Injury Using siRNA -- Preventing Immune Rejection Through Gene Silencing -- Topical Application of siRNA Targeting Cutaneous Dendritic Cells in Allergic Skin Disease -- Direct Application of siRNA for In Vivo Pain Research -- A Potential Therapeutic for Pandemic Influenza Using RNA Interference -- Evaluation of Targets for Ovarian Cancer Gene Silencing Therapy: In Vitro and In Vivo Approaches.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Laboratory medicine.
|
| 650 |
1 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Laboratory Medicine.
|
| 700 |
1 |
|
|a Min, Wei-Ping.
|e editor.
|
| 700 |
1 |
|
|a Ichim, Thomas.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|